This is a demo store. No orders will be fulfilled.
Carrier Free
products
💡 What does Carrier Free Grade mean? Learn more about Carrier Free standards and purity criteria ⮕
-
Recombinant Kex2 ProteaseCas Number: 99676-46-7Species: Baker's yeast Accession #: P13134Expression system: Pichia pastoris Protein Tag: No tag Endotoxin Concentration: <0.1 EU/μgBioactivity: Specific Activity: ≥10U/mg pro. UNIT DEFINITION: Under the conditions of 25°C and pH 8.0, the amount of enzyme needed to catalyze the conversion of 1 μmol Boc-QR R-pNA into products per minute is one enzyme activity unit (U).Synonyms: KEX 2 | Kex2p | Kexin | KEX2 | QDS1 | SRB1 | VMA45 -
Recombinant Human beta 2 Microglobulin ProteinSpecies: Human Accession #: P61769Expression system: HEK293 Protein Tag: C-His Endotoxin Concentration: <0.1 EU/μgBioactivity: Immobilized Recombinant Human B2M at 2 μg/mL (100 μL/well) can bind Recombinant Human CD8 alpha with a linear range of 30-350 ng/mL.Synonyms: B2M | B2MG_HUMAN | Beta 2 microglobin | Beta 2 microglobulin | Beta 2 microglobulin precursor | Beta chain of mhc cla...
-
Adalimumab (anti-TNF-alpha)Short Overview: Purity>95% (SDS-PAGE&SEC); Endotoxin Level < 0.01EU/μg ; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; UnconjugatedSpecies reactivity（Reacts with): Cynomolgus monkey, Human, Mouse, Rhesus monkey Isotype: Human IgG1Host species: Human Conjugation: UnconjugatedCas Number: 331731-18-1 EC Number: 695-701-7IUPAC Name: 2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acidSMILES: CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)OInChIKey: BTGNGJJLZOIYID-UHFFFAOYSA-NInChI: InChI=1S/C20H22N2O7S/c1-20(2,3)19(26)29-13-8-10-14(11-9-13)30(27,28)22-16-7-5-4-6-15(16)18(25)21-12-17(23)24/h4-11,22H,12H2,1-3H3,(H,21,25)(H,23,24)Synonyms: dl-N-Acetylhomocysteinethiolactone | ONO5046;LY544349;EI546 | SIVELESTAT [INN] | SIVELESTAT [MART.] | 2,2-Dimethyl-pr...
-
TGF beta Mouse mAbShort Overview: mAb (1D11.16.8); Mouse anti Human/Mouse/Rat/Monkey/Hamster/Dog/Cow TGF beta Antibody; Neutralization, WB; UnconjugatedSpecies reactivity（Reacts with): Cow, Dog, Hamster, Human, Monkey, Mouse, Rat Isotype: Mouse IgG1Host species: Mouse Clone number: 1D11.16.8 Conjugation: UnconjugatedSynonyms: Cartilage-inducing factor antibody | CED antibody | Differentiation inhibiting factor antibody | DPD1 antibody | LAP ...
-
Recombinant IFNγ AntibodyAssociated targets: IFNGShort Overview: Recombinant (R4-6A2); Rat anti Mouse IFNγ Antibody; Flow, in vivo/vitro IFNγ neutralization; UnconjugatedSpecies reactivity（Reacts with): Mouse Isotype: Rat IgG1Host species: Rat Clone number: R4-6A2 Conjugation: UnconjugatedSynonyms: Ifg | If2f | IFN-g | IFI | IFNG | IFNgamma | IFN-gamma | Immune interferon | interferon gamma | interferon, gamma | I...
-
CD25 Rat mAbAssociated targets: IL2RAShort Overview: mAb (PC-61.5.3); Rat anti Mouse CD25 Antibody; Flow Cytometry, WB, in vivo regulatory T cell depletion; UnconjugatedSpecies reactivity（Reacts with): Mouse Isotype: Rat IgG1Host species: Rat Clone number: PC-61.5.3 Conjugation: UnconjugatedSynonyms: CD25 Rat mAb | CD25, Il2r, Ly-43 | Interleukin 2 receptor alpha chain antibody | CD25 antibody | CD25 antigen antibod...
-
Avelumab (anti-PD-L1)Associated targets: CD274Short Overview: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; UnconjugatedSpecies reactivity（Reacts with): Cynomolgus monkey, Dog, Human, Mouse, Rabbit, Rat Isotype: Human IgG1Host species: Human Conjugation: UnconjugatedCas Number: 1537032-82-8 Compound CID: 168266339IUPAC Name: show more
SMILES: show more InChIKey: YRKYEQYAGDIKGE-UHFFFAOYSA-NInChI: show more Synonyms: Recombinant Avelumab Antibody | Avelumab | Anti-Human PD-L1, Human Antibody | Anti-PD-L1 | MSB0010718C | Bavencio | B...
-
Camrelizumab (anti-PD-1)Associated targets: PDCD1Short Overview: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG4SP; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; UnconjugatedSpecies reactivity（Reacts with): Cynomolgus monkey, Human Isotype: Human IgG4SPHost species: Human Conjugation: UnconjugatedCas Number: 1798286-48-2Synonyms: SHR-1210 | CD279 antigen | CD279 | hPD-1 | PD1 | PD-1 | PD1hPD-l | PDCD1 | programmed cell death 1 | programmed cell ...
-
Cemiplimab (anti-PD-1)Associated targets: PDCD1Short Overview: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4; CHO; ELISA, FACS, Functional assay, Animal Model; UnconjugatedSpecies reactivity（Reacts with): Human Isotype: Human IgG4Host species: Human Conjugation: UnconjugatedCas Number: 1801342-60-8Synonyms: hPD-1 | Protein PD-1
-
Daratumumab (anti-CD38)Associated targets: CD38Short Overview: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; UnconjugatedSpecies reactivity（Reacts with): Cynomolgus monkey, Human, Mouse, Rhesus monkey Isotype: Human IgG1Host species: Human Conjugation: UnconjugatedCas Number: 945721-28-8Synonyms: 2.4.99.20 | 2'-phospho-ADP-ribosyl cyclase | 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase ...
-
Durvalumab (anti-PD-L1)Associated targets: CD274Short Overview: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<0.01EU/μg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; UnconjugatedSpecies reactivity（Reacts with): Cynomolgus monkey, Human, Mouse Isotype: Human IgG1Host species: Human Conjugation: UnconjugatedCas Number: 1428935-60-7Synonyms: Durvalumab (anti-PD-L1) | MEDI4736 | Durvalumab | MEDI 4736 | Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (durvalum...
-
Infliximab (anti-TNF-alpha)Associated targets: TNFShort Overview: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; UnconjugatedSpecies reactivity（Reacts with): Cynomolgus monkey, Human Isotype: Human IgG1Host species: Human Conjugation: UnconjugatedCas Number: 170277-31-3Synonyms: Infliximab | Remicade | Remsima | Inflectra | Avakine | CT-P13 | APC1 antibody | APC1 protein antibody | Cachectin an...
